Teva’s Shared Solutions® offers in-person support from dedicated Clinical Nurse Educators (CNEs) who focus on educating patients about RMS and COPAXONE® therapy, and offer support through injection training and patient programs. These committed professionals partner with you in order to keep your patients feeling cared for and on track throughout their therapy.
Increased patient confidence in managing injections
Reinforce proper injection technique
Personal injection plans to help patients achieve therapy goals
Personalized overall support
Free, in-home injection and refresher training available at any point to reinforce patient motivation
High-level support to encourage patient adherence
Follow-up reporting on patient progress
Direct connection to Teva’s Shared Solutions® resources and injection supplies
Increased access to training, education, and overall support for your patients
Education and support programs that connect patients with RMS community and with each other
Connection to resources that aid compliance and adherence
Assistance in understanding available support resources and financial options
Personalized, one-on-one counseling to help patients understand the basics of RMS and injection training for COPAXONE®
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of
The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.
While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.